Quadrature Capital’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
Other funds holding FENC
ACM
AIC
PCA
Quadrature Capital's FENC Position: Q3 2026 in Review
Quadrature Capital reduced its Fennec Pharmaceuticals (FENC) stake by 80% in Q3 2026, selling an estimated $666K and leaving 15,104 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #1816.
Quadrature Capital first reported a position in FENC in Q3 2025 and has held it in 4 quarters since. The position peaked at $814K in Q2 2026. 119 funds tracked by Wall St. Rank hold FENC as of Q3 2026.
- Quadrature Capital held 15,104 shares of Fennec Pharmaceuticals worth $161K as of Q3 2026.
- Quadrature Capital sold 60,622 Fennec Pharmaceuticals shares in Q3 2026, an estimated $666K.
- Fennec Pharmaceuticals made up ﹤0.01% of Quadrature Capital's portfolio in Q3 2026, its #1816 holding.
- Quadrature Capital first reported a position in Fennec Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- Quadrature Capital's Fennec Pharmaceuticals position peaked at $814K in Q2 2026.
- 119 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.
Based on Quadrature Capital's 13F filing for Q3 2026, filed 13 Nov 2026.